The reality is that hundreds of thousands of women and men will be diagnosed with invasive and in situ breast cancer this year, and it will take about 40,290 women's and 440 men's lives in the United States and 522,000 women worldwide
National Breast Cancer Coalition (NBCC)
Breast Cancer Coalition (NBCC) has a unique history and an unmatched record of accomplishment in breast cancer. Since our inception in 1991, our mission has been to end breast cancer. NBCC has a long history of taking on big issues, challenging business as usual, facing controversy head on and achieving success.
NBCC is quite different from other breast cancer organizations. We are about challenging the status quo, catalyzing research and science, leveraging existing resources and giving those diagnosed and those at risk of breast cancer the tools to make decisions for themselves. Our achievements range from generating more than $3.3 billion of federal funding for breast cancer research to creating a system of access to health care for uninsured women with breast and cervical cancer to launching international training programs in science and health care; but it's simply not enough. Despite years of campaigns to raise awareness, ever expanding screening programs, increased fundraising efforts and research, breast cancer incidence and mortality have not changed significantly. The reality is that hundreds of thousands of women and men will be diagnosed with invasive and in situ breast cancer this year, and this disease will take about 40,290 women's and 440 men's lives in the United States and 522,000 women worldwide.
While the vast majority of resources are focused on finding the next treatment, NBCC is doing something very different. We are bringing together unprecedented collaborations among scientists, visionaries, and advocates to catalyze, plan and implement work in two major areas: how to prevent metastasis to save lives and how to prevent the disease from developing in the first instance.
In March 2010, we began looking at the feasibility of a preventive vaccine for breast cancer. As a result, NBCC established the Artemis Project?" to develop and implement a five-year strategic plan for a preventive vaccine. Some of the leading breast cancer researchers, as well as a cadre of multi-disciplinary visionaries, are participating in this venture. Beginning with a baseline report in May 2011, NBCC has issued Annual Progress Reports about Breast Cancer Deadline 2020". These reports summarize the state of breast cancer as well as the status of NBCCs work to end breast cancer, holding us and the entire breast cancer community accountable. Along with these programmatic efforts, NBCC has undertaken an effort to change the conversation around breast cancer to a dialogue about knowing how to end the disease by January 1, 2020. Through the use of cutting-edge web tools, education and training, new activists will be engaged to spread the word about Breast Cancer Deadline 2020?" across the globe. With a unique history and an unmatched record of accomplishment in breast cancer, NBCC links hundreds of organizations and tens of thousands of individuals from across the country into a dynamic, diverse coalition to achieve the goals of Breast Cancer Deadline 2020?". Achieving our goal will be difficult, but until we end breast cancer, NBCC will never give up and never back down. Breast Cancer Deadline 2020?" - we will know how to end breast cancer by January 1, 2020.